Reverse Line Probe Hybridization Assay for Detection of Lamivudine-Resistant Chronic Hepatitis B Virus

Aiping Huang
2012-01-01
Abstract:Objective: To establish a simple,rapid,sensitive and accurate reserve line probe(RLP) method for the detection of chronic HBV(hepatitis B virus) lamivudine-resistant locus.Methods: Based on the gene sequence of HBV wild-type and lamivudine-resistant drug,universal probe,specific probe of 3',5' added poly-C and primers of 5' labeled biotin were designed.The specific probes were fixed on the nitrocellulose membrane linear;so as to make HBV PCR amplification products hybridize with the probes.By optimizing the hybridization conditions,a reverse line probe hybridization test method was established,which was then used to detect 86 chronic hepatitis B patients in Chongqing,and the results were compared with those of the direct sequencing method.Results: On the condition that HBV DNA in the serum had more than 103 copies/ml,it could be amplified effectively by semi-nested PCR.At the same time,when cDNA was more than 1ng/ml or the mutant proportion was more than 5% in wild-type of serum samples,lamivudine-resistant to chronic hepatitis B virus could be effectively detected by the new RLP hybridization method.The sensitivity in 86 clinic cases was 100%(86/86).The detection accuracy of the wild type and the drug resistant type was 98.09%(103/105),100%(43/43),respectively.Conclusions: The reverse linear probe hybridization method to HBV lamivudine resistance is convenient,sensitive and accurate.It is an effective monitoring tool for HBV lamivudine therapy and suitable for clinical application.
What problem does this paper attempt to address?